南京中生聯合股份有限公司- H 股 03332Prospectus Information

Prospectus Information
Company Overview
Stock Name南京中生聯合股份有限公司- H 股
Stock Code03332
Company Full Name南京中生聯合股份有限公司- H 股
Industry醫療保健
Principal Activities主要在中國從事制造及銷售營養膳食補充劑及保健食品。
Listing Date2014-01-15
Listing Rules EraOld Rules
Listing Rules ChapterTo be extracted
Weighted Voting Rights (WVR)No
Registered Address (Mainland China)中國江蘇省南京市玄武區長江路188號德基大廈30樓
Business Address (Hong Kong)To be extracted
Place of IncorporationTo be extracted
Listing MethodTo be extracted
Listing BoardMain Board
Websitehttp://www.zs-united.com
Share Registrar
Registrar Contact(852)2862 8628
A-Share/US Dual ListingNo data
Offering Information
Offering Mechanism To be extracted
Offer PriceHK$ 2.00 / shares
Offer Price RangeTo be extracted
Lot SizeTo be extracted
Entry ThresholdTo be extracted
Par ValueTo be extracted
Offer PeriodTo be extracted
Global Offering SharesTo be extracted
HK Public Offer Shares (Initial)To be extracted
Public Offer Lots (Initial)To be extracted
International Placing Shares (Initial)To be extracted
Offer RatioTo be extracted
Total Shares Post-IPOTo be extracted
Greenshoe (Over-allotment Option)To be confirmed
Stabilizing Manager (Greenshoe)
Cornerstone Share2.7%
Clawback TiersTo be extracted
Reallocation OptionTo be confirmed
Total Global Offering SizeHK$ 203,800,000
Valuation & Financials
Market Cap (at Offer Price)To be extracted
Pre-IPO Valuation (Last Round)To be extracted
P/E RatioTo be extracted
Profit/Loss StatusTo be extracted
Period-End Cash BalanceTo be extracted
Listing ExpensesTo be extracted
Listing Expenses / Funds RaisedTo be extracted
Total Pre-IPO InvestmentTo be extracted
First Day Performance
First Day CloseHK$ 2.66
First Day OpenHK$ 2.78
First Day Change33.00%
First Day Volume179746000.0
First Day Turnover492908000.0
Use of Proceeds
Use of Proceeds1、約43%(或143.6百萬港元)將用于擴張我們位于江蘇省南京市的生產設施,其中: a 約31%(或103.6百萬港元)將用于建設一條新生產線,以制造軟膠囊劑、罐裝粉劑及迷你瓶裝飲料形式的產品,設計年產能分別為800,000劑、650,000劑及2,000,000劑; b 約6%(或20.0百萬港元)將用于建設一個研發測試中心;及 c 約6%(或20.0百萬港元)將用于設立一個信息及物流控制中心; 2、約34%(或113.5百萬港元)將于未來兩年內用于為我們的營銷及推廣活動提供資金,借以提高中生及康培爾品牌在全國范圍內的品牌知名度,其中: a 約23%(或76.8百萬港元)將用于電視、印刷品、電臺及網上廣告; b 約6%(或20.0百萬港元)將用于聘請明星代言人; c 約3%(或10.0百萬港元)將用于通過創作及推出新企業宣傳片、新產品包裝設計及新營銷材料以推廣及提升我們的企業及品牌形象; d 約2%(或6.7百萬港元)將用于在主要節假日于中國各地舉行的推廣活動; 3、 約18%(或68.5百萬港元)將用于在未來數年內加強及擴張我們的現有銷售網絡,并滲透至新區域,尤其是中國一線城市、省會及富裕的二線城市,其中: a 約6%(或22.8百萬港元)將用于支持我們2014年的銷售網絡擴張。根據當前的市況,我們現擬在2014年年底前分別將中生零售店數目及康培爾零售店數目增加至45家及72家; b 約12%(或45.7百萬港元)將用于支持我們2015年及2016年的銷售網絡擴張。視乎當時的宏觀經濟環境及我們產品的市場需求,按開設中生零售店及康培爾零售店的最低資金需求計算,所得款項將足以讓我們在2015年及2016年分別再開設20家及80家中生零售店及康培爾零售店; 4、余下約5%(或19百萬港元)將用作我們的營運資金及其他一般企業用途。
Underwriting Syndicate
Sole Sponsor (1)
BOCOM International (Asia) Limited CE API271
Overall Coordinators (1)
交银国际证券有限公司 CE APJ121
Joint Bookrunners (1)
交银国际证券有限公司 CE APJ121
Joint Lead Managers (1)
交银国际证券有限公司 CE APJ121
Cornerstone Investors
#Investor NameInvestment AmountShares Subscribed% of Offer Shares% of Total SharesLock-up PeriodEst. Unlock Date
1 康健企业咨询及投资有限公司 44,304,000 HKD 2.70% 6 months 2014-07-15
Directors & Management
Chairman桂平湖
Company Secretary支卉;游子麟
No director data available.
Major Shareholders
Major Shareholders & Holdings桂平湖(6.46%);桂客(6.46%);彭少衍(6.29%)
Disclaimer & Risk Warning

Site Nature: This website (cibo.qizai.ai) is an independent technology product showcase platform established by Panda Securities Limited (CE Number: BNC380). This website itself and all content displayed herein do not constitute and are not involved in any regulated activity or licensed service.

Not Investment Advice: The data on this page is automatically extracted from prospectus PDFs by AI and may contain omissions or errors. All information and data on this page are sourced from prospectuses and related historical documents, are not real-time data, and will not be automatically updated, reflecting historical information at the time of prospectus publication. All content is provided solely for AI tool analysis learning exchange and technical reference purposes, and absolutely does not constitute any investment advice, offer to buy or sell, solicitation, recommendation, or guarantee. The output of this AI analysis tool should not be interpreted as investment opinion.

Decision Responsibility: Users should make investment decisions based on their own independent judgment and consult independent licensed financial advisors when needed. Neither the Company nor this AI analysis tool shall bear any responsibility for any investment decisions made by users based on the information on this page.

Separation from Panda Securities Official Website: The content of this website is strictly distinct from the SFC-regulated licensed services provided by Panda Securities' official website (fafa.hk). No securities trading or account opening or other regulated operations can be conducted through this website.

Panda Securities Limited is a licensed corporation regulated by the Hong Kong SFC (CE Number: BNC380) and a Hong Kong Exchange Participant (Participant ID: 02229). Use of this website constitutes acceptance of this disclaimer.

Cibo — IPO & Market Data Analytics